BriaCell Therapeutics Corp. Warrant expiring 2031
BCTXL
Last
$1.10
Day
+0.0%
1y
+19.4%
5y
+19.4%
52w
-20.7%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
1.08
EMA 50
1.01
EMA 200
0.96
20d high
-9.8%
5y high
-20.7%
5y range
63th
Positions held
Your positionsBCTXL isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
42
Hold
swing
Signal
Strong Buy
Target
$1.40
Stop
$0.97
Stop distance
11.8%
Target vs last
+27.3%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.33 | Beta | 1.51 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.8% | ROA | -90.8% | Debt / equity | — |
| Current ratio | 7.07 | Free cash flow | -$20.04M | Analyst recommendation | none | Mean target | — |
| 52w high | $1.15 | 52w low | $1.05 |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsBCTXL · daily+8.8% over 14 sessions
Close EMA21 EMA50 EMA200